The short answer
Indapamide can lower potassium, making monitoring and adequate intake important. Your prescriber should decide whether supplements are needed from your results and risk factors.
What this answer covers
Adequate dietary potassium and clinician-directed oral potassium replacement during indapamide treatment. Potassium salts and potassium-containing combination products require individual review.
- Supplement or preparation
- Potassium
- Medication ingredient
- indapamide
Indapamide can lower potassium
The medicine’s own studies and labeling document potassium reductions, with greater risk at higher doses and in susceptible patients. Potassium checks are part of treatment, especially after starting or changing therapy and when other risks are present. Your prescriber should set the schedule.
A supplement is not automatic
Some low potassium measurements in the label’s trials returned to normal without intervention. A newer low-dose study also had normal average potassium values, but involved a selected population. These findings support an individual plan, rather than giving everyone the same replacement dose.
Review diet, kidney function and other medicines
Tell your care team if you have poor intake, vomiting, diarrhea, kidney disease or take medicines that also affect potassium. Kidney function and the full regimen matter when choosing a potassium product or dose. Do not start salt substitutes or potassium tablets without checking their contents with the pharmacist.
Symptoms deserve assessment
Report new muscle weakness, cramps, marked fatigue or palpitations. Low magnesium can make low potassium harder to correct, so the clinician may assess both. Severe weakness, fainting or significant heart-rhythm symptoms need urgent medical attention rather than home treatment with supplements.
Evidence and practical considerations
Timing & monitoring
Indapamide can lower potassium, so potassium monitoring and adequate intake matter; supplements should be based on the individual clinical situation.
- Exact scope
- Adequate dietary potassium and clinician-directed oral potassium replacement during indapamide treatment. Potassium salts and potassium-containing combination products require individual review. with Exact indapamide RxCUI 5764 IN, confirmed by current NLM properties. Oral indapamide dose and release formulation are retained; evidence for hydrochlorothiazide, other diuretics or combination antihypertensive products is not automatically equivalent.
- Medication form and route
- Oral
What remains uncertain
- Risk varies with dose, illness, kidney function and other medicines. Not every low value needs the same intervention, and lower-dose selected trials do not establish zero risk. No universal supplement prescription.
Factors that may matter: Dose and duration; Exact supplement preparation; Kidney function; Other medicines; Baseline electrolyte status.
Read the supporting source summaries
Source 1: Current U.S. prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral indapamide 1.25 or 2.5 mg tablets; additional dose-ranging study data.
Recommends periodic electrolyte and renal-function assessment. Potassium reductions were dose-related; some low measurements normalized without intervention. Calcium increases in indapamide studies were only slight. Includes a thiazide-like magnesium-loss warning.
How this applies: Exact medication guidance with explicit dose and nutrient distinctions. Exact indapamide RxCUI 5764 IN, confirmed by current NLM properties. Oral indapamide dose and release formulation are retained; evidence for hydrochlorothiazide, other diuretics or combination antihypertensive products is not automatically equivalent.
A label class warning is not proof that every patient has magnesium depletion or that routine supplements are required. Higher-dose risks and other diuretics cannot be assigned to every low-dose regimen.
Source 2: Current prescribing information
medicines.org.uk · Source check Sep 10, 2026
Population: Patients prescribed oral indapamide 2.5 mg.
Calcium salts may increase hypercalcemia risk through reduced urinary calcium elimination. Stimulant laxatives add to hypokalemia risk; non-stimulant laxatives are advised. Low potassium increases arrhythmia risk, particularly with long QT or digitalis, and may cause muscle injury. Low magnesium can make low potassium refractory.
How this applies: Exact indapamide guidance supports conditional calcium/laxative and electrolyte-management conclusions.
Regulatory guidance, not direct clinical trials for every botanical. Does not establish universal supplement requirements, a fixed supplement dose or protective spacing.
Source 3: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 11 patients with essential hypertension.
Urinary calcium fell without a serum calcium change; moderate hypokalemia occurred.
How this applies: Exact drug renal handling, not proof that supplements always cause high calcium.
Small study with no calcium-supplement intervention. Original fullTextXML request failed; abstract-only.
Source 4: Original clinical research
ebi.ac.uk · Source check Sep 10, 2026
Population: 101 adults with idiopathic hypercalciuria, randomized to indapamide or hydrochlorothiazide; 83 completed 18 months.
Indapamide reduced urinary calcium. Mean magnesium, sodium and potassium remained within normal ranges; the severe hypokalemia event occurred in the hydrochlorothiazide arm.
How this applies: Exact low-dose indapamide counterweight to universal electrolyte-depletion claims, with population and comparator boundaries.
Open-label selected kidney-stone population, attrition and group-average outcomes. Excluded calcium and vitamin D supplementation, so cannot establish safety of co-use. No fracture-prevention conclusion.
Source 5: Authoritative medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Medication terminology.
Identifies indapamide as IN.
How this applies: Exact medication identifier.
Does not establish formulation equivalence or a clinical interaction.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: 7a71cec38599beb1
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.